Abbaszadeh Z,Çeşmeli S,Biray Avcı C .2020 .Crucial players in glycolysis: Cancer progress. Gene, 726 : 144158.
Ashrafizadeh M .2024 .Cell death mechanisms in human cancers: Molecular pathways, therapy resistance and therapeutic perspective. J. Can. Biomol. Therap., 1(1) : 17-40.
Cao M,Ren Y,Li Y,Deng J,Su X,Tang Y,Yuan F,Deng H,Yang G,He Z,Liu B,Yao Z,Deng M .2023 .Lnc-ZEB2-19 inhibits the progression and lenvatinib resistance of hepatocellular carcinoma by attenuating the NF-κB signaling pathway through the TRA2A/RSPH14 axis. Int. J. Biol. Sci., 19(12) : 3678-3693.
Chelakkot C,Chelakkot VS,Shin Y,Song K Y .2023 .Modulating glycolysis to improve cancer therapy. Int. J. Mol. Sci, 24(3) : 2606.
Chen K,Li Y,Wang B,Yan X,Tao Y,Song W,Xi Z,He K,Xia Q K .2023 .Patient-derived models facilitate precision medicine in liver cancer by remodeling cellmatrix interaction. Front. Immunol., 14 : 1101324.
Chen Y,Jiang Y,Huang X,Chen L,Yang H,Zhao J,Liang B .2022 .Cordycepin inhibits the growth of hepatocellular carcinoma by regulating the pathway of aerobic glycolysis. Evid. Based Complement. Alternat. Med, 6454482 : .
Chidambaranathan-Reghupaty S,Fisher PB,Sarkar D PB .2021 .Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification. Adv. Cancer Res., 149 : 1-61.
Cogliati B,Yashaswini CN,Wang S,Sia D,Friedman SL .2023 .Friend or foe? The elusive role of hepatic stellate cells in liver cancer. Nat. Rev. Gastroenterol. Hepatol., 20(10) : 647-661.
Dai H,Li M,Yang W,Sun X,Wang P,Wang X,Su J,Wang X,Hu X,Zhao M .2020 .Resveratrol inhibits the malignant progression of hepatocellular carcinoma via MARCH1-induced regulation of PTEN/AKT signaling. Aging, 12(12) : 11717-11731.
Fei M,Li X,Liang S,Zhou S,Wu H,Sun L,Liu Y,Hu Q,Liu L,Wang J .2024 .LncRNA PWRN1 inhibits the progression of hepatocellular carcinoma by activating PKM2 activity. Cancer Lett., 584 : 216620.
Feng J,Li J,Wu L,Yu Q,Ji J,Wu J,Dai W,Guo C .2020 .Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma. J. Exp. Clin. Cancer Res., 39(1) : 126.
Gao X,Liu J,Fan D,Li X,Fang Z,Yan K,Fan Y .2022 .Berberine enhances gemcitabine-induced cytotoxicity in bladder cancer by downregulating Rad51 expression through inactivating the PI3K/Akt pathway. Oncol. Rep, 47(2) : 33.
Habtemariam S .2020 .Berberine pharmacology and the gut micro biota: A hidden therapeutic link. Pharmacol. Res., 155 : 104722.
Hassanipour S,Vali M,Gaffari-Fam S,Nikbakht HA,Abdzadeh E,Joukar F,Pourshams A,Shafaghi A,Malakoutikhah M,Arab-Zozani M,Salehiniya H,Mansour-Ghanaei F .2020 .The survival rate of hepatocellular carcinoma in Asian countries: A systematic review and meta-analysis. EXCLI J, 19 : 108-130.
Hinshaw DC,Shevde LA .2019 .The tumor microenvironment innately modulates cancer progression. Cancer Res., 79(18) : 4557-4566.
Huang R,Zhang L,Jin J,Zhou Y,Zhang H,Lv C,Lu D,Wu Y,Zhang H,Liu S,Chen H,Luan X,Zhang W .2021 .Bruceine D inhibits HIF-1α-mediated glucose metabolism in hepatocellular carcinoma by blocking ICAT/β-catenin interaction. Acta Pharma. Sini. B., 11(11) : 3481-3492.
Jampasri S,Reabroi S,Tungmunnithum D,Parichatikanond W,Pinthong D .2022 .Plumbagin suppresses breast cancer progression by downregulating HIF-1α expression via a PI3K/Akt/mTOR independent pathway under hypoxic condition. , 27(17) : 5716.
Jiang N,Zhao H,Han Y,Li L,Xiong S,Zeng L,Xiao Y,Wei L,Xiong X,Gao P,Yang M,Liu Y,Sun L Y .2020 .HIF-1α ameliorates tubular injury in diabetic nephropathy via HO-1-mediated control of mitochondrial dynamics. Cell Prolif, 53(11) : e12909.
Kheshtchin N and Hadjati J .2022 .Targeting hypoxia and hypoxia-inducible factor-1 in the tumor microenvironment for optimal cancer immunotherapy. J. Cell Physiol, 237(2) : 1285-1298.
Kierans SJ,Taylor CT SJ .2021 .Regulation of glycolysis by the hypoxia-inducible factor (HIF): implications for cellular physiology. J. Physiol, 599(1) : 23-37.
Viatour Kim E,P Kim E .2020 .Hepatocellular carcinoma: old friends and new tricks. Exp. Mol. Med, 52(12) : 1898-1907.
Li J,Dan W,Zhang C,Liu N,Wang Y,Liu J,Zhang S J .2024 .Exploration of berberine against ulcerative colitis via TLR4/NF-κB/HIF-1α pathway by bioinformatics and experimental validation. Drug Des. Devel. Ther., 18 : 2847-2868.
Lin Y,Guo L Y .2022 .GLI1 is involved in HIF-1α- induced migration, invasion, and epithelialmesenchymal transition in glioma cells. Folia Histochem Cytobiol., 60(2) : 156-166.
Liu L,Fan J,Ai G,Liu J,Luo N,Li C .2019 .Berberine in combination with cisplatin induces necroptosis and apoptosis in ovarian cancer cells. Biol. Res., 52(1) : 37.
Liu Z,Liu X,Liang J,Liu Y,Hou X,Zhang M,Li Y,Jiang X Y .2021 .Immunotherapy for hepatocellular carcinoma: Current status and future prospects. Front. Immunol., 12 : 765101.
Och A,Podgórski R,Nowak R .2020 .Biological activity of berberine-A summary update. Toxins, 12(11) : 713.
Paul S,Ghosh S,Kumar S S .2022 .Tumor glycolysis, an essential sweet tooth of tumor cells. Semin. Cancer Biol, 86 : 1216-1230.
Piñero F,Dirchwolf M,Pessoa MG M .2020 .Biomarkers in hepatocellular carcinoma: Diagnosis, prognosis and treatment response assessment. Cells, 9(6) : 1370.
Rashid M,Zadeh LR,Baradaran B,Molavi O,Ghesmati Z,Sabzichi M,Ramezani F M .2021 .Up-down regulation of HIF-1α in cancer progression. Gene, 798 : 145796.
Rauf A,Abu-Izneid T,Khalil AA,Imran M,Shah ZA,Emran TB,Mitra S,Khan Z,Alhumaydhi FA,Aljohani ASM,Khan I,Rahman MM,Jeandet P,Gondal T A .2021 .Berberine as a potential anticancer agent: A comprehensive review. Molecules, 26(23) : 7368.
Rumgay H,Arnold M,Ferlay J,Lesi O,Cabasag CJ,Vignat J,Laversanne M,McGlynn KA,Soerjomataram I .2022 .Global burden of primary liver cancer in 2020 and predictions to 2040. , 77(6) : 1598-1606.
Sarcognato S,Sacchi D,Fassan M,Fabris L,Cadamuro M,Zanus G,Cataldo I,Capelli P,Baciorri F,Cacciatore M,Guido M M .2021 .. Cholangiocarcinoma. Pathologica, 113(3) : 158-169.
Song D,Hao J,Fan D J .2020 .Biological properties and clinical applications of berberine. Front. Med, 14(5) : 564-582.
Sun K,Wu L,Wang S,Deng W .2022 .Antitumor effects of Chinese herbal medicine compounds and their nano-formulations on regulating the immune system microenvironment. Front. Oncol., 12 : 949332.
Sun Y,Zhou Q,Chen F,Gao X,Yang L,Jin X,Wink M,Sharopov FS,Sethi G .2023 .Berberine inhibits breast carcinoma proliferation and metastasis under hypoxic microenvironment involving gut microbiota and endogenous metabolites. Pharmacol. Res., 193 : 106817.
Sung H,Ferlay J,Siegel RL,Laversanne M,Soerjomataram I,Jemal A,Bray F A,Clin A .2020 .GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Global cancer statistics, 71(3) : 209-249.
Vaupel P and Multhoff G .2021 .Revisiting the Warburg effect: Historical dogma versus current understanding. J. Physiol., 599(6) : 1745-1757.
Vishnoi K,Ke R,Saini KS,Viswakarma N,Nair RS,Das S,Chen Z,Rana A,Rana B .2021 .Berberine represses β-Catenin translation involving 4E-BPs in hepatocellular carcinoma cells. Mol. Pharmacol, 99(1) : 1-16.
Wada H,Nagano H,Yamamoto H,Yang Y,Kondo M,Ota H,Nakamura M,Yoshioka S,Kato H,Damdinsuren B,Tang D,Marubashi S,Miyamoto A,Takeda Y,Umeshita K,Nakamori S,Sakon M,Dono K,Wakasa K,Monden M K .2006 .Expression pattern of angiogenic factors and prognosis after hepatic resection in hepatocellular carcinoma: Importance of angiopoietin-2 and hypoxia-induced factor-1 alpha. , 26(4) : 414-423.
Wang K,Chen Q,Shao Y,Yin S,Liu C,Liu Y,Wang R,Wang T,Qiu Y,Yu H Y .2021 .Anticancer activities of TCM and their active components against tumor metastasis. Biomed, 133 : 111044.
Wang Y,Yang Y,Yang Y,Dang Y,Guo Z,Zhuang Q,Zheng X,Wang F,Cheng N,Liu X,Guo W,Zhao B .2023 .Hypoxia induces hepatocellular carcinoma metastasis via the HIF-1α/METTL16/lnc-CSMD1- 7/RBFOX2 axis. , 26(12) : 108495.
Xiao H,Tong R,Cheng S,Lv Z,Ding C,Du C,Xie H,Zhou L,Wu J,Zheng S J .2014 .BAG3 and HIF-1 α coexpression detected by immunohistochemistry correlated with prognosis in hepatocellular carcinoma after liver transplantation. BioMed. Res. Int., 516518 : .
Xiao Y,Yu D Y .2021 .Tumor microenvironment as a therapeutic target in cancer. Pharmacol, 221 : 107753.
Xie L,Dai H,Li M,Yang W,Yu G,Wang X,Wang P,Liu W,Hu X,Zhao M .2019 .MARCH1 encourages tumour progression of hepatocellular carcinoma via regulation of PI3K-AKT-β-catenin pathways. J. Cell. Mol. Med, 23(5) : 3386-3401.
Xiong RG,Huang SY,Wu SX,Zhou DD,Yang ZJ,Saimaiti A,Zhao CN,Shang A,Zhang YJ,Gan RY,Li HB .2022 .Anticancer effects and mechanisms of berberine from medicinal herbs: An update review. Molecules, 27(14) : 4523.
Xu M,Ren L,Fan J,Huang L,Zhou L,Li X,Ye X .2022 .Berberine inhibits gastric cancer development and progression by regulating the JAK2/STAT3 pathway and downregulating IL-6. , 290 : 120266.
Yu Q,Dai W,Ji J,Wu L,Feng J,Li J,Zheng Y,Li Y,Zhang Z,Wu J,Xu J,Guo X,C X,Cell X .2022 .Sodium butyrate inhibits aerobic glycolysis of hepatocellular carcinoma cells via the cmyc/hexokinase 2 pathway. Mol. Med, 26(10) : 3031-3045.
Zeng X,Wan L,Wang Y,Xue J,Yang H,Zhu Y H .2020 .Effect of low dose of berberine on the radioresistance of cervical cancer cells via a PI3K/HIF1 pathway under nutrient-deprived conditions. Int. J. Radiat. Biol, 96(8) : 1060-1067.
Zhao Y,Xing C,Deng Y,Ye C,Peng H C .2024 .HIF1α signaling: Essential roles in tumorigenesis and implications in targeted therapies. Genes Dis., 11(1) : 234-251.
Zheng F,Li J,Ma C,Tang X,Tang Q,Wu J,Chai X,Xie J,Yang XB,Hann SS .2020 .Novel regulation of. , : .